The potential role of Plasma gelsolin in dialysis-related protein-energy wasting

Blood Purification

Volumn 29, Issue 2, 2010, Pages 99-101

  Lee, Po Shun ^a   Bhan, Ishir ^b   Thadhani, Ravi ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Gelsolin; Kidney failure; Protein energy malnutrition; Renal dialysis; Wasting syndrome

Indexed keywords

GELSOLIN;

ACUTE LUNG INJURY; BURN; CHRONIC KIDNEY DISEASE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN CALORIE MALNUTRITION; SEPSIS; SHORT SURVEY; WASTING SYNDROME;

ACTINS; BIOLOGICAL MARKERS; GELSOLIN; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; KIDNEY FAILURE, CHRONIC; LIPIDS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; PROTEIN-ENERGY MALNUTRITION; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 77749317187     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000245632     Document Type: Short Survey

References (25)

1. Meyer TW, Hostetter TH: Uremia. N Engl J Med 2007; 357: 1316-1325.
2. de Mutsert R, Grootendorst DC, Axelsson J, Boeschoten EW, Krediet RT, Dekker FW, Group NS: Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. Nephrol Dial Transplant 2008; 23: 2957-2964.
3. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Trevino-Becerra A, Wanner C: A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73: 391-398.
4. Rambod M, Bross R, Zitterkoph J, Benner D, Pithia J, Colman S, Kovesdy CP, Kopple JD, Kalantar-Zadeh K: Association of malnutrition-inflammation score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis 2009; 53: 298-309.
5. Lecker SH, Goldberg AL, Mitch WE: Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol 2006; 17: 1807-1819.
6. Kwiatkowski DJ, Mehl R, Izumo S, Nadal-Ginard B, Yin HL: Muscle is the major source of plasma gelsolin. J Biol Chem 1988; 263: 8239-8243.
7. Kwiatkowski DJ, Stossel TP, Orkin SH, Mole JE, Colten HR, Yin HL: Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature 1986; 323: 455-458.
8. Lee PS, Sampath K, Karumanchi SA, Tamez H, Bhan I, Isakova T, Gutierrez OM, Wolf M, Chang Y, Stossel TP, Thadhani R: Plasma gelsolin and circulating actin correlate with hemodialysis mortality. J Am Soc Nephrol 2009; 20: 1140-1148.
9. Kwiatkowski DJ, Mehl R, Yin HL: Genomic organization and biosynthesis of secreted and cytoplasmic forms of gelsolin. J Cell Biol 1988; 106: 375-384.
10. Allen PG: Functional consequences of disulfide bond formation in gelsolin. FEBS Lett 1997; 401: 89-94.
11. Kwiatkowski DJ: Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr Opin Cell Biol 1999; 11: 103-108.
12. Lee WM, Galbraith RM: The extracellular actin-scavenger system and actin toxicity. N Engl J Med 1992; 326: 1335-1341.
13. Osborn TM, Dahlgren C, Hartwig JH, Stossel TP: Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin. Am J Physiol Cell Physiol 2007; 292:C1323-C1330.
14. Bucki R, Byfield FJ, Kulakowska A, McCormick ME, Drozdowski W, Namiot Z, Hartung T, Janmey PA: Extracellular gelsolin binds lipoteichoic acid and modulates cellular response to proinflammatory bacterial wall components. J Immunol 2008; 181: 4936-4944.
15. Bucki R, Georges PC, Espinassous Q, Funaki M, Pastore JJ, Chaby R, Janmey PA: Inactivation of endotoxin by human plasma gelsolin. Biochemistry 2005; 44: 9590-9597.
16. Di Nubile MJ, Stossel TP, Ljunghusen OC, Ferrara JL, Antin JH: Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantation. Blood 2002; 100: 4367-4371.
17. Lee PS, Drager LR, Stossel TP, Moore FD, Rogers SO: Relationship of plasma gelsolin levels to outcomes in critically ill surgical patients. Ann Surg 2006; 243: 399-403.
18. Lee PS, Patel SR, Christiani DC, Bajwa E, Stossel TP, Waxman AB: Plasma gelsolin depletion and circulating actin in sepsis: a pilot study. PLoS One 2008; 3:e3712.
19. Mounzer KC, Moncure M, Smith YR, Di Nubile MJ: Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma. Am J Respir Crit Care Med 1999; 160: 1673-1681.
20. Lind SE, Smith DB, Janmey PA, Stossel TP: Depression of gelsolin levels and detection of gelsolin-actin complexes in plasma of patients with acute lung injury. Am Rev Respir Dis 1988; 138: 429-434.
21. Osborn T, Verdrengh M, Stossel T, Tarkowski A, Bokarewa M: Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis. Arthritis Res Ther 2008; 10:R117.
22. Lee PS, Waxman AB, Cotich KL, Chung SW, Perrella MA, Stossel TP: Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit Care Med 2007; 35: 849-855.
23. Rothenbach PA, Dahl B, Schwartz JJ, O'Keefe GE, Yamamoto M, Lee WM, Horton JW, Yin HL, Turnage RH: Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J Appl Physiol 2004; 96: 25-31.
24. Christofidou-Solomidou M, Scherpereel A, Solomides CC, Christie JD, Stossel TP, Goelz S, Di Nubile MJ: Recombinant plasma gelsolin diminishes the acute inflammatory response to hyperoxia in mice. J Investig Med 2002; 50: 54-60.
25. Lind SE, Smith DB, Janmey PA, Stossel TP: Role of plasma gelsolin and the vitamin Dbinding protein in clearing actin from the circulation. J Clin Invest 1986; 78: 736-742.